Startups

PolyProx Therapeutics is a developer of a novel class of drug intended to provide new therapies for cancer treatment.

Summary

Seedtable Score
  • 4
Locations
Company Size
  • 1 to 10 employees
Last Stage Round

Total funding Amount

$5.7M

Fundraising History

Investors